Related Experiment Video
Updated: Mar 31, 2026
06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
15.0K
Protecting Quantum Dot Fluorescence from Quenching to Achieve a Reliable Automated Multiplex Fluorescence In Situ
Journal of Biomedical Nanotechnology
|October 22, 2015
Summary
Quantum dots (QDs) offer superior brightness and stability for fluorescence in situ hybridization (FISH). Optimized QD FISH methods enhance reliability, enabling their use as a clinical diagnostic tool for genetic analysis.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Nanotechnology
Background:
- Quantum dots (QDs) are advanced inorganic fluorochromes with superior brightness, photostability, and spectral resolution compared to traditional dyes.
- Quantum dot-based fluorescence in situ hybridization (QD FISH) offers potential for enhanced resolution and signal intensity in molecular diagnostics.
- Reliability issues have hindered the widespread clinical adoption of QD FISH technology.
Purpose of the Study:
- To optimize QD FISH protocols to improve assay reliability and overcome limitations for clinical applications.
- To develop a robust QD FISH staining procedure that enhances QD accessibility and protects fluorescence.
- To validate the enhanced QD FISH assay for detecting various genetic markers across different cancer types.
Main Methods:
- Developed an optimized QD FISH staining procedure focusing on QD-to-target accessibility.
- Implemented methods to protect QD fluorescence from heavy metal quenching and minimize background signals.
- Validated the assay on automated ERG/PTEN QD FISH for prostate cancer, and tested for HER2, ALK, and HPV16 detection.
Main Results:
- Achieved a 91% first-pass rate for an automated ERG/PTEN QD FISH assay, significantly improving reliability.
- Demonstrated highly consistent staining in prostate tissue and successful detection of multiple clinically relevant genetic markers.
- Showcased enhanced reliability for HER2 gene status in breast cancer, ALK in lung cancer, and HPV16 in cervical neoplasia.
- The optimized QD FISH assay enabled detection of complex genetic aberrations without enzymatic amplification.
Conclusions:
- Optimized QD FISH protocols significantly enhance assay reliability and consistency.
- The improved QD FISH technology is suitable for clinical diagnostic applications, including complex genetic analyses.
- This advancement paves the way for broader clinical implementation of QD FISH for various molecular pathology needs.
